Gluten-dependent enteropathy and atypical human leukocyte antigen alleles.

[1]  C. Wijmenga,et al.  A genetic perspective on coeliac disease. , 2010, Trends in molecular medicine.

[2]  L. Sollid,et al.  Tissue-mediated control of immunopathology in coeliac disease , 2009, Nature Reviews Immunology.

[3]  E. Bergseng,et al.  Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation , 2009, Nature Immunology.

[4]  R. Nakamura,et al.  Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  D. Jewell,et al.  Contribution of histological, serological, and genetic factors to the clinical heterogeneity of adult-onset coeliac disease , 2009, Scandinavian journal of gastroenterology.

[6]  Tsung-Teh Wu,et al.  Lymphocytic Duodenosis and the Spectrum of Celiac Disease , 2009, The American Journal of Gastroenterology.

[7]  R. Anderson,et al.  Coeliac disease: current approach and future prospects , 2008, Internal medicine journal.

[8]  T. Macdonald,et al.  Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease , 2007, Gut.

[9]  L. Sollid,et al.  Mechanisms of Disease: immunopathogenesis of celiac disease , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[10]  P. Ciclitira,et al.  The pathogenesis of coeliac disease. , 2005, Molecular aspects of medicine.

[11]  P. Ciclitira,et al.  Clinical features and diagnosis of celiac disease. , 2005, Gastroenterology.

[12]  Seiamak Bahram,et al.  A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. , 2004, Immunity.

[13]  Govind Bhagat,et al.  Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. , 2004, Immunity.

[14]  S. Pereira,et al.  The pathogenesis of coeliac disease. , 2004, The international journal of biochemistry & cell biology.

[15]  F. Koning,et al.  The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Vahid Asnafi,et al.  Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. , 2003, Gastroenterology.

[17]  V. Raia,et al.  Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease , 2003, The Lancet.

[18]  L. Greco,et al.  HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. , 2003, Human immunology.

[19]  S. Mcmillan,et al.  Sensitivity of serum tissue transglutaminase antibodies for endomysial antibody positive and negative coeliac disease. , 2001, Scandinavian journal of gastroenterology.

[20]  R. Jian,et al.  Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease☆☆☆ , 2000, Gastroenterology.

[21]  R. Houlston,et al.  Relative power of linkage and transmission disequilibrium test strategies to detect non-HLA linked coeliac disease susceptibility genes , 1999, Gut.

[22]  K. Lundin,et al.  Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. , 1998, Gastroenterology.

[23]  L. Fugger,et al.  Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease , 1998, Nature Medicine.

[24]  F. Cucca,et al.  A gene dosage effect of the DQA1*0501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. , 1994, Human immunology.

[25]  E. Thorsby,et al.  On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. , 1993, Tissue antigens.

[26]  K. Welsh,et al.  HLA class II alleles associated with celiac disease susceptibility in a southern European population. , 1992, Tissue antigens.

[27]  J. Visakorpi,et al.  Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. , 1990, Archives of disease in childhood.

[28]  E. Thorsby,et al.  Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer , 1989, The Journal of experimental medicine.

[29]  S. Rendine,et al.  HLA-DR3 and DR7 in coeliac disease: immunogenetic and clinical aspects. , 1983, Gut.